Layal Bou Harfouch
Drug Policy Analyst, Reason Foundation
Layal Bou Harfouch is a drug policy analyst at Reason Foundation.
-
How bad housing policy fuels homelessness, and how to fix it
Integrating harm reduction strategies with housing first models may create a sustainable path forward that is both compassionate and effective.
-
Will Martin Makary’s FDA listen to the evidence on e-cigarettes?
Instead of demonizing e-cigarettes, Trump's FDA should recognize them as a resource for public health.
-
Medicaid is failing people leaving prison, and we’re all paying the price
Addressing Medicaid’s shortcomings isn’t just about fiscally responsible solutions; it’s about empowering individuals to jumpstart their reentry to society.
-
RFK Jr.’s opioid crisis plan
While Kennedy's opioid recovery journey may have worked for him, his proposal overlooks other evidence-based approaches.
-
Nonconsensual drug testing raises serious ethical concerns
When hospitals take on roles similar to law enforcement, they betray their core mission: delivering compassionate, patient-centered care.
-
Harm reduction recommendations for the Trump administration
It's time for a comprehensive drug policy that makes meaningful strides toward reducing overdose deaths, supporting recovery, and fostering healthier, more resilient communities.
-
Unreliable drug tests shouldn’t be used to separate mothers from their newborns
Informed consent and confirmatory testing should be standards for any drug testing that could affect a mother’s parental rights.
-
Why smoking cessation programs should embrace vaping
Contrary to widespread belief, there is substantial proof that e-cigarettes are a viable and successful cessation tool.
